As with any medication, consultation with a healthcare provider is essential to weigh the benefits against the risks and determine the most suitable course of action
Clinical trial data from the STEP programme show that these side effects are most frequent during the dose escalation period and tend to reduce over time as the body adjusts to the medication
Platforms like MeAgain centralize injection schedules, symptom and injection-site tracking, hydration and protein goals, and exportable timelines, giving clinicians a coherent dataset to act on and patients a simple way to show progress without repeating the same story at every visit
In infrequent instances, tirzepatide may also elevate the risk of certain thyroid tumor types
Serious side effects are possible including acute secondary angle closure glaucoma, decreased sweating and increased boy temperature, metabolic acidosis, suicidal ideation, kidney stones, and fetal toxicity